- Home
- BGR vs MRVI Comparison
BGR vs MRVI Comparison
Compare BGR & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGR
- MRVI
- Stock Information
- Founded
- BGR 2004
- MRVI 2014
- Country
- BGR United States
- MRVI United States
- Employees
- BGR N/A
- MRVI N/A
- Industry
- BGR Trusts Except Educational Religious and Charitable
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- BGR Finance
- MRVI Health Care
- Exchange
- BGR Nasdaq
- MRVI Nasdaq
- Market Cap
- BGR 321.9M
- MRVI 262.9M
- IPO Year
- BGR N/A
- MRVI 2020
- Fundamental
- Price
- BGR $12.77
- MRVI $2.06
- Analyst Decision
- BGR
- MRVI Hold
- Analyst Count
- BGR 0
- MRVI 10
- Target Price
- BGR N/A
- MRVI $6.84
- AVG Volume (30 Days)
- BGR 73.3K
- MRVI 1.8M
- Earning Date
- BGR 01-01-0001
- MRVI 05-12-2025
- Dividend Yield
- BGR 6.02%
- MRVI N/A
- EPS Growth
- BGR N/A
- MRVI N/A
- EPS
- BGR 0.69
- MRVI N/A
- Revenue
- BGR N/A
- MRVI $241,856,000.00
- Revenue This Year
- BGR N/A
- MRVI N/A
- Revenue Next Year
- BGR N/A
- MRVI $11.14
- P/E Ratio
- BGR $18.97
- MRVI N/A
- Revenue Growth
- BGR N/A
- MRVI N/A
- 52 Week Low
- BGR $11.38
- MRVI $1.67
- 52 Week High
- BGR $13.37
- MRVI $11.56
- Technical
- Relative Strength Index (RSI)
- BGR 56.91
- MRVI 47.79
- Support Level
- BGR $12.29
- MRVI $1.96
- Resistance Level
- BGR $12.64
- MRVI $2.16
- Average True Range (ATR)
- BGR 0.20
- MRVI 0.13
- MACD
- BGR 0.08
- MRVI 0.04
- Stochastic Oscillator
- BGR 82.86
- MRVI 25.97
About BGR BlackRock Energy and Resources Trust
BlackRock Energy & Resources Trust is a closed-end equity fund providing total return through a combination of current income, gains and capital appreciation by investing in equity securities and derivatives of energy and natural resources companies. The fund invests in various sectors such as information technology, financials, healthcare, consumer discretionary, industrial, energy, materials and utilities.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.